Exercise Collapse Associated with Sickle Cell Trait (ECAST): Case Report and Literature Review

Sickle cell trait (SCT) has been associated with exertional collapse (ECAST) and exercise-related sudden death in athletes and military warfighters. The mechanisms underlying ECAST remain controversial in the sports medicine community. Multiple case presentations and anecdotal reports postulate the role of extraordinary exercise intensity, but other risk factors including dehydration, heat, previous exertional rhabdomyolysis, genetic cofactors, and dietary supplements have been cited as potential contributors. Others have hypothesized some of the aforementioned factors combining in a “perfect storm” to trigger ECAST with a resultant potentially fatal “metabolic crisis.” This case report provides a brief review of SCT as it pertains to exercise in warfighters and athletes, identifies known and postulated risk factors associated with ECAST, and introduces the potential mechanistic role of the “double hit” as a contributor to ECAST.

[1]  M. Fornage,et al.  Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA. , 2017, Blood.

[2]  P. Laforêt,et al.  Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy? , 2016, BMJ Open Sport & Exercise Medicine.

[3]  James Hu,et al.  Rhabdomyolysis After Ankle Strain and Light Cycling , 2016, Journal of clinical medicine research.

[4]  E. Eichner.  Preventing exertional sickling deaths: the right way, the wrong way, and the Army way. , 2013, Current sports medicine reports.

[5]  H. Bunn,et al.  The triumph of good over evil: protection by the sickle gene against malaria. , 2013, Blood.

[6]  J. Whitehead,et al.  ACSM and CHAMP summit on sickle cell trait: mitigating risks for warfighters and athletes. , 2012, Medicine and science in sports and exercise.

[7]  K. Harmon,et al.  Sickle cell trait associated with a RR of death of 37 times in national collegiate athletic association football athletes: a database with 2 million athlete-years as the denominator , 2012, British Journal of Sports Medicine.

[8]  G. Huber,et al.  Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane. , 2012, Biophysical journal.

[9]  V. Bonham,et al.  Framing the research agenda for sickle cell trait: Building on the current understanding of clinical events and their potential implications , 2012, American journal of hematology.

[10]  E. Eichner,et al.  Exertional sickling deaths in Army recruits with sickle cell trait. , 2012, Military medicine.

[11]  M. Treadwell,et al.  Screening U.S. college athletes for their sickle cell disease carrier status. , 2011, American journal of preventive medicine.

[12]  S. Walsh,et al.  Sudden exertional death in sickle cell trait , 2011, British Journal of Sports Medicine.

[13]  Paola Sebastiani,et al.  Fetal hemoglobin in sickle cell anemia. , 2011, Blood.

[14]  E. Eichner,et al.  Sickle cell considerations in athletes. , 2011, Clinics in sports medicine.

[15]  N. Key,et al.  Sickle-cell trait: novel clinical significance. , 2010, Hematology. American Society of Hematology. Education Program.

[16]  E. Eichner.  Sickle Cell Trait in Sports , 2010, Current sports medicine reports.

[17]  V. Bonham,et al.  Screening student athletes for sickle cell trait--a social and clinical experiment. , 2010, The New England journal of medicine.

[18]  D. Gozal,et al.  Skeletal muscle structural and energetic characteristics in subjects with sickle cell trait, alpha-thalassemia, or dual hemoglobinopathy. , 2010, Journal of applied physiology.

[19]  E. Eichner,et al.  Sickle cell trait and fatal rhabdomyolysis in football training: a case study. , 2010, Medicine and science in sports and exercise.

[20]  N. Sambuughin,et al.  Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms. , 2010, Anesthesiology.

[21]  S. Perrey,et al.  Lactate Removal Ability and VO 2 . Recovery Kinetics in Sickle Cell Trait Carriers Compared with Normal Haemoglobin Subjects: Preliminary Data , 2009 .

[22]  Y. Amoateng-Adjepong,et al.  Complications associated with sickle cell trait: a brief narrative review. , 2009, The American journal of medicine.

[23]  W. Morgan,et al.  Lower airway obstruction is associated with increased morbidity in children with sickle cell disease , 2009, Pediatric pulmonology.

[24]  O. Hue,et al.  This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Physiological Responses of Sickle Cell Trait Carriers during Exercise , 2008 .

[25]  E. Eichner.  Sickle cell trait. , 2007, Journal of sport rehabilitation.

[26]  G. Seda,et al.  A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement. , 2007, Military medicine.

[27]  E. Eichner.  Sports medicine pearls and pitfalls—sickle cell trait and athletes: Three clinical concerns , 2007, Current sports medicine reports.

[28]  R. Massarelli,et al.  Effects of progressive and maximal exercise on plasma levels of adhesion molecules in athletes with sickle cell trait with or without alpha-thalassemia. , 2007, Journal of applied physiology.

[29]  S. Racinais,et al.  Does the Pattern of Repeated Sprint Ability Differ between Sickle Cell Trait Carriers and Healthy Subjects? , 2006, International journal of sports medicine.

[30]  N. Longo,et al.  Disorders of carnitine transport and the carnitine cycle , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

[31]  O. Hue,et al.  Effects of short supramaximal exercise on hemorheology in sickle cell trait carriers , 2006, European Journal of Applied Physiology.

[32]  R. Massarelli,et al.  Hemorheology, sickle cell trait, and alpha-thalassemia in athletes: effects of exercise. , 2005, Medicine and science in sports and exercise.

[33]  A. Munnich,et al.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. , 2004, Molecular aspects of medicine.

[34]  A. Kutlar,et al.  Interaction of Sickle Cell Trait with Hereditary Spherocytosis: Splenic Infarcts and Sequestration , 2002, Acta Haematologica.

[35]  A. Symeonidis,et al.  Non Hypoxia-Related Splenic Infarct in a Patient with Sickle Cell Trait and Infectious Mononucleosis , 2001, Acta Haematologica.

[36]  J. Kark,et al.  Exercise and hemoglobin S. , 1994, Seminars in hematology.

[37]  H. Meiselman,et al.  Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity. , 1994, The American journal of pediatric hematology/oncology.

[38]  Beverley McNeil,et al.  Malignant Hyperthermia , 2005, Springer US.

[39]  J. Kark,et al.  Sickle-cell trait as a risk factor for sudden death in physical training. , 1987, The New England journal of medicine.

[40]  K. Adachi,et al.  Polymerization of AS hybrid hemoglobin. Potent inhibitory effect of hemoglobin A on the polymerization of AS hybrid hemoglobin. , 1984, The Journal of biological chemistry.

[41]  J. Hofrichter,et al.  Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. , 1974, Proceedings of the National Academy of Sciences of the United States of America.